Scientific Reports (Nov 2022)

Validation of days alive and out of hospital as a new patient-centered outcome to quantify life impact after heart transplantation

  • René M’Pembele,
  • Sebastian Roth,
  • Alexandra Stroda,
  • Tilman Reier,
  • Giovanna Lurati Buse,
  • Stephan U. Sixt,
  • Ralf Westenfeld,
  • Philipp Rellecke,
  • Igor Tudorache,
  • Markus W. Hollmann,
  • Hug Aubin,
  • Payam Akhyari,
  • Artur Lichtenberg,
  • Ragnar Huhn,
  • Udo Boeken

DOI
https://doi.org/10.1038/s41598-022-21936-4
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 10

Abstract

Read online

Abstract The number of patients waiting for heart transplantation (HTX) is increasing. Thus, identification of outcome-relevant factors is crucial. This study aimed to identify perioperative factors associated with days alive and out of hospital (DAOH)—a patient-centered outcome to quantify life impact—after HTX. This retrospective cohort study screened 187 patients who underwent HTX at university hospital Duesseldorf, Germany from September 2010 to December 2020. The primary endpoint was DAOH at 1 year. Risk factors for mortality after HTX were assessed in univariate analysis. Variables with significant association were entered into multivariable quantile regression. In total, 175 patients were included into analysis. Median DAOH at 1 year was 295 (223–322) days. In univariate analysis the following variables were associated with reduced DAOH: recipient or donor diabetes pre-HTX, renal replacement therapy (RRT), VA-ECMO therapy, recipient body mass index, recipient estimated glomerular filtration rate (eGFR) and postoperative duration of mechanical ventilation. After adjustment, mechanical ventilation, RRT, eGFR and recipient diabetes showed significant independent association with DAOH. This study identified risk factors associated with reduced DAOH at 1-year after HTX. These findings might complement existing data for outcome of patients undergoing HTX.